Ezra E W Cohen Selected Research

Ezra E W Cohen Research Topics

Disease

70	Neoplasms (Cancer) 03/2022 - 05/2003
56	Squamous Cell Carcinoma of Head and Neck 03/2022 - 05/2003
36	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022 - 05/2004
9	Thyroid Neoplasms (Thyroid Cancer) 12/2015 - 05/2006
7	Exanthema (Rash) 10/2019 - 09/2012
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2015 - 10/2002
6	Fatigue 12/2019 - 10/2010
4	Neoplasm Metastasis (Metastasis) 01/2021 - 12/2004
4	Stomatitis 10/2019 - 05/2015
4	Nausea 10/2019 - 10/2010
4	Diarrhea 10/2019 - 06/2013
4	medullary Thyroid cancer 12/2016 - 07/2011
4	Mucositis 10/2013 - 10/2010
3	Hemorrhage 10/2020 - 04/2008
3	Melanoma (Melanoma, Malignant) 10/2020 - 12/2014
3	Disease Progression 01/2020 - 03/2009
3	Papillary Thyroid Cancer 09/2016 - 04/2012
3	Mouth Neoplasms (Oral Cancer) 02/2016 - 05/2010
3	Neutropenia 05/2015 - 04/2008
2	Carcinoma (Carcinomatosis) 03/2022 - 01/2020
2	Inflammation (Inflammations) 01/2022 - 11/2016
2	Salivary Gland Neoplasms (Salivary Gland Cancer) 01/2020 - 07/2011
2	Pneumonia (Pneumonitis) 12/2019 - 06/2014
2	Acne Vulgaris 10/2019 - 05/2015
2	Osteoradionecrosis 01/2010 - 07/2008
2	Fistula 07/2008 - 04/2008
2	Necrosis 07/2008 - 04/2008
2	Hypoxia (Hypoxemia) 06/2008 - 12/2004
2	Carcinogenesis 04/2008 - 12/2006
1	Tertiary Lymphoid Structures 11/2021

Drug/Important Bio-Agent (IBA)

18	ErbB Receptors (EGF Receptor)IBA 02/2016 - 05/2003
12	PlatinumIBA 01/2021 - 05/2011
10	Biomarkers (Surrogate Marker)IBA 12/2019 - 05/2011
9	pembrolizumabIBA 03/2022 - 01/2019
9	Cetuximab (Erbitux)FDA Link 01/2021 - 02/2010
9	Gefitinib (Iressa)FDA Link 06/2013 - 05/2003
8	Pharmaceutical PreparationsIBA 01/2022 - 06/2013
8	IodineIBA 09/2016 - 05/2006
8	Tyrosine Kinase InhibitorsIBA 05/2015 - 11/2005
7	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 03/2007
7	Bevacizumab (Avastin)FDA Link 01/2019 - 04/2008
6	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2019
6	AfatinibIBA 10/2019 - 06/2013
6	Axitinib (AG 013736)IBA 04/2015 - 10/2008
5	Phosphotransferases (Kinase)IBA 01/2020 - 11/2005
5	Erlotinib Hydrochloride (CP 358,774)FDA Link 02/2016 - 06/2008
4	Peptides (Polypeptides)IBA 01/2022 - 01/2016
4	AntibodiesIBA 01/2022 - 12/2019
4	Methotrexate (Mexate)FDA LinkGeneric 12/2019 - 04/2009
4	Fluorouracil (Carac)FDA LinkGeneric 01/2019 - 04/2008
4	cabozantinibIBA 12/2016 - 07/2011
3	Immunoconjugates (Immunoconjugate)IBA 01/2022 - 01/2020
3	RNA (Ribonucleic Acid)IBA 01/2020 - 02/2010
3	LigandsIBA 12/2019 - 02/2010
3	Carboplatin (JM8)FDA LinkGeneric 08/2019 - 10/2002
3	Sirolimus (Rapamycin)FDA Link 01/2018 - 04/2011
3	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2016 - 04/2008
3	Biological ProductsIBA 01/2016 - 04/2012
3	Proteins (Proteins, Gene)FDA Link 01/2016 - 06/2006
3	Sunitinib (Sutent)FDA Link 11/2015 - 10/2010
3	DNA (Deoxyribonucleic Acid)IBA 08/2015 - 01/2009
2	auristatinIBA 01/2022 - 01/2020
2	AntigensIBA 01/2021 - 01/2019
2	MTOR InhibitorsIBA 01/2021 - 01/2019
2	NivolumabIBA 05/2020 - 01/2019
2	Monoclonal AntibodiesIBA 12/2019 - 12/2006
2	Docetaxel (Taxotere)FDA Link 12/2019 - 09/2007
2	Metformin (Glucophage)FDA LinkGeneric 01/2019 - 01/2018
2	CytokinesIBA 01/2018 - 11/2016
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2016 - 12/2004
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2015 - 12/2006
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 12/2014 - 10/2008
2	Iodine-131IBA 01/2014 - 04/2012
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 10/2013 - 05/2012
2	Proto-Oncogene Proteins c-metIBA 10/2013 - 04/2009
2	Sorafenib (BAY 43-9006)FDA Link 01/2013 - 04/2011
2	Lapatinib (GW572016)FDA Link 04/2012 - 08/2009
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2009 - 04/2008
1	Agammaglobulinaemia Tyrosine KinaseIBA 03/2022
1	acalabrutinibIBA 03/2022
1	Toll-Like Receptor 9IBA 01/2022
1	monomethyl auristatin EIBA 01/2022
1	B7-H1 AntigenIBA 01/2021
1	Cancer VaccinesIBA 01/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2021
1	VaccinesIBA 01/2021
1	Small Interfering RNA (siRNA)IBA 01/2021
1	Everolimus FDA Link 01/2021
1	talimogene laherparepvecIBA 10/2020

Therapy/Procedure

40	Therapeutics 03/2022 - 10/2002
21	Drug Therapy (Chemotherapy) 01/2021 - 05/2004
19	Radiotherapy 01/2020 - 10/2002
18	Chemoradiotherapy 01/2020 - 07/2006
15	Immunotherapy 01/2022 - 01/2008
8	Induction Chemotherapy 01/2016 - 02/2004
4	Re-Irradiation 10/2011 - 03/2007
2	Drug Tapering 10/2013 - 10/2010
2	Laryngectomy 10/2012 - 07/2012
2	Dental Care 05/2012 - 05/2010
2	Adjuvant Chemoradiotherapy 07/2011 - 08/2009